Life Extension Innovations, Moonshots & Snake Oil (with Celine Halioua & James Peyer)

Approval Process

The drug approval process is a complex landscape where various stakeholders play crucial roles. James Peyer explains that while doctors can prescribe drugs off-label, insurance companies and biotech companies have restrictions on promoting drugs for unapproved uses 1. Celine Halioua highlights the challenges faced by unconventional founders in gaining credibility within the biotech industry 2. She notes, "I take that responsibility super seriously because I want them to invest in more companies after us and more weird companies."

I take that responsibility super seriously because I want them to invest in more companies after us and more weird companies.

--- Celine Halioua

Navigating these challenges requires balancing innovative ideas with conservative approaches to ensure success and credibility.

   

Regulatory Hurdles

Regulatory challenges in the aging and longevity drug sector are significant, with only a small percentage of drugs making it through clinical trials. Celine Halioua describes Loyal's strategy of developing multiple programs to mitigate risk, emphasizing the importance of proving efficacy to the FDA 3. James Peyer adds that biotech companies have slightly better approval rates than traditional pharma, but the odds remain challenging 4.

This is the hardest part of pharma, that only statistically, only about 12% of drugs that start clinical trials get approved.

--- James Peyer

These hurdles necessitate strategic planning and innovation to increase the likelihood of success in this burgeoning field.